Predicting rectal and bladder overdose during the course of prostate radiotherapy using dose-volume data from initial treatment fractions.

[1]  M. Kattan,et al.  Is it time to tailor the prediction of radio-induced toxicity in prostate cancer patients? Building the first set of nomograms for late rectal syndrome. , 2012, International journal of radiation oncology, biology, physics.

[2]  Z. Master,et al.  Dose variation during hypofractionated image-guided radiotherapy for prostate cancer: planned versus delivered. , 2011, Journal of cancer research and therapeutics.

[3]  V. Choudhary,et al.  Treatment results of high dose rate interstitial brachytherapy in carcinoma of eye lid. , 2011, Journal of cancer research and therapeutics.

[4]  Xia Li,et al.  Clinical and dosimetric factors associated with acute rectal toxicity in patients treated with (131)Cs brachytherapy for prostate cancer. , 2010, Brachytherapy.

[5]  M. V. van Herk,et al.  Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics. , 2010, International journal of radiation oncology, biology, physics.

[6]  Niko Papanikolaou,et al.  QA for helical tomotherapy: Report of the AAPM Task Group 148a). , 2010, Medical physics.

[7]  G. Sanguineti,et al.  Dose-volume effects for normal tissues in external radiotherapy: pelvis. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  B. Fallone,et al.  Prostate positioning errors associated with two automatic registration based image guidance strategies , 2009, Journal of applied clinical medical physics.

[9]  C. Ménard,et al.  RTOG GU Radiation oncology specialists reach consensus on pelvic lymph node volumes for high-risk prostate cancer. , 2009, International journal of radiation oncology, biology, physics.

[10]  Patrick A Kupelian,et al.  Impact of image guidance on outcomes after external beam radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[11]  G. Gustafson,et al.  Predictors for chronic urinary toxicity after the treatment of prostate cancer with adaptive three-dimensional conformal radiotherapy: dose-volume analysis of a phase II dose-escalation study. , 2007, International journal of radiation oncology, biology, physics.

[12]  Lei Dong,et al.  Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer. , 2007, International journal of radiation oncology, biology, physics.

[13]  R. Holloway,et al.  Hypofractionated versus conventionally fractionated radiation therapy for prostate carcinoma: updated results of a phase III randomized trial. , 2006, International journal of radiation oncology, biology, physics.

[14]  M. Hoogeman,et al.  Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer. , 2005, International journal of radiation oncology, biology, physics.

[15]  G. Gustafson,et al.  Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy. , 2005, International journal of radiation oncology, biology, physics.

[16]  W. J. Morris,et al.  Randomized trial comparing two fractionation schedules for patients with localized prostate cancer. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[17]  George Starkschall,et al.  Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. , 2002, International journal of radiation oncology, biology, physics.

[18]  Rick Chappell,et al.  Is α/β for prostate tumors really low? , 2001 .

[19]  R. Pötter,et al.  Rectal sequelae after conformal radiotherapy of prostate cancer: dose-volume histograms as predictive factors. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[20]  D. Brenner,et al.  Direct evidence that prostate tumors show high sensitivity to fractionation (low α/β ratio), similar to late-responding normal tissue , 2002 .